Wei JS

No ORCID on file · 1 paper in corpus
2012
Frontiers in oncology ·doi:10.3389/fonc.2012.00194

Technological advances now allow us to rapidly produce CARs and other antibody-derived therapeutics targeting cell surface receptors. To maximize the potential of these new technologies, relevant extracellular targets must be identified. Th…